It has been confirmed in numerous studies that serum CEA, CA19-9, and CA72-4 are all common clinical serum tumor markers for gastric cancer, with considerable clinical significance in the diagnosis and treatment of gastric cancer. The gene discussed is CEACAM5; the disease is neoplasm.